BrightEdge
Atlanta, Georgiaacsbrightedge.org
Overview
BrightEdge is the innovation, impact investment, and venture capital arm of the American Cancer Society, investing in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CellCentric | May 2026 | Series D | Co-investor |
| Deck Bio | Apr 2026 | Seed | Co-investor |
| TippingPoint Biosciences | Mar 2026 | Seed | Co-investor |
| Cellens Inc. | Dec 2025 | Seed | Co-investor |
| Paradigm Health | Dec 2025 | Series B | Co-investor |
Key People
Amy Berg 🟦
Principal, Philanthropy
Jack Chapon
Venture Capital Investment Intern
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
